Cartwright Alyssa M, Shaw Justin T, Traiger Dean
Internal Medicine, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Family Medicine, Physicians' Primary Care of Southwest Florida, Cape Coral, USA.
Cureus. 2023 Mar 14;15(3):e36158. doi: 10.7759/cureus.36158. eCollection 2023 Mar.
Bupropion is an antidepressant utilized widely for the treatment of various mood disorders and smoking cessation due to its favorable side effect profile, cost, and response to therapy. While serious adverse reactions are rare, in the decades since its approval by the FDA, multiple cases of serum sickness-like reactions to bupropion have been reported, amongst other adverse drug reactions (ADRs). This report is of the case of a 25-year-old female who developed a serum sickness-like reaction to bupropion 21 days after initiation of treatment. She did not respond to conservative therapy but did respond promptly to oral corticosteroids and discontinuation of bupropion. This case serves to bolster the existing literature surrounding ADRs to bupropion and other antidepressant medications in the categories of systemic and dermatologic manifestations.
安非他酮是一种广泛用于治疗各种情绪障碍和戒烟的抗抑郁药,因其副作用小、成本低且对治疗有反应。虽然严重不良反应很少见,但自美国食品药品监督管理局(FDA)批准以来的几十年里,除了其他药物不良反应(ADR)外,还报告了多例安非他酮引起的血清病样反应。本报告是关于一名25岁女性的病例,她在开始治疗21天后出现了安非他酮引起的血清病样反应。她对保守治疗无反应,但对口服皮质类固醇和停用安非他酮反应迅速。该病例有助于加强现有关于安非他酮和其他抗抑郁药物在全身和皮肤表现方面的药物不良反应的文献。